START Center Partners with Trialing to Expand Oncology Trial Access Across Europe

The collaboration leverages Trialing’s platform to connect physicians with early-phase cancer studies and provide real-time updates on patient enrolment opportunities.

START’s partnership with Trialing aims to streamline referrals and increase physician awareness of ongoing oncology trials, improving patient access to innovative therapies.

By sharing dynamic study information and eligibility updates, the initiative supports faster, more transparent connections between physicians and clinical trial sites across Europe.

Alert Type	Clinical Trial / Partnership
Drug/Device Name	N/A – Clinical Trial Access Platform
Indication	Oncology – Early-phase cancer trials
Therapy Area(s)	Haematology / Oncology
Geography	Europe
What Changed	START Center for Cancer Research has partnered with Trialing to improve access to early-phase oncology trials across Europe, leveraging Trialing’s platform to connect physicians with active studies and notify them of patient enrolment opportunities.
Clinical Relevance	Enhances referral pathways, increases physician awareness of ongoing trials, and enables real-time updates on eligibility and enrolment, improving patient access to innovative cancer therapies.
Source Link	START Press Release
Date	09-Mar-2026
Status	Draft
Notes	Trialing’s platform supports rapid study identification using structured decision pathways; START continues to expand its European trial network and has prior collaborations, including Fundación Rioja Salud in Spain.

---

Discover how nuaxia can support your next medical education initiative:

• Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector 

• Contact us on: support@nuaxia.com